From STAT’s Elaine Chen: Earlier this month, the FDA updated the labels of GLP-1 drugs to warn of the risk of patients ...

WASHINGTON, D.C. — Following scientific review by the U.S. Food and Drug Administration (FDA), the agency issued a renewal of ...

Following a scientific review, the Food and Drug Administration (FDA) has issued a renewal of modified risk granted orders to ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

CBS News' Jericka Duncan spoke to Amber Thurman's family and the ProPublica reporter whose investigation found doctors waited ...

The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.

Quarterly reports from the biotech sector are falling from the skies like spring pollen and the wise companies are augmenting ...

with its PulseSelect system gaining the FDA’s clearance in December 2023 for use in paroxysmal and persistent AF. Electrophysiologists also have the Farapulse system (Boston Scientific), approved in ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...